DJIA 16,262.56 0.00 0.00%
NASDAQ 4,034.16 0.00 0.00%
S&P 500 1,842.98 0.00 0.00%
market minute promo

7.92 0.00 (0.00%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

SUPN $7.92 0.00%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $7.81
Previous Close $7.92
Daily Range $7.28 - $7.92
52-Week Range $4.45 - $10.55
Market Cap $333.0M
P/E Ratio -2.69
Dividend (Yield) $0.00 (0.0%)
Volume 454,759
Average Daily Volume 637,641
Current FY EPS -$0.81

Sector

Healthcare

Industry

Drugs

Supernus Pharmaceuticals (SUPN) Description

Supernus Pharmaceuticals Inc specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system or CNS diseases. Website: http://www.supernus.com/

News & Commentary Rss Feed

This Week in Biotech

An FDA approval, a mixed batch of clinical data, a welcome pipeline update, and an ongoing patent battle are this week's must-watch biotech stories.

Oversold Conditions For Supernus Pharmaceuticals (SUPN)

Commit To Buy Supernus Pharmaceuticals At $5, Earn 26% Using Options

Is Supernus Pharmaceuticals (SUPN) Stock a Solid Choice Right Now? - Tale of the Tape

4 Stocks Under $10 Making Big Moves

Supernus Pharmaceuticals: 2013 Revenues Exceed Analyst & Company Expectations; Maintaining Positive

Supernus Pharmaceuticals: 2013 Revenues Exceed Analyst & Company Expectations; Maintaining Positive Outlook

SUPN: 2013 Revenues Exceed Analyst & Company Expectations; Maintaining Positive Outlook

Supernus Pharmaceuticals' CEO Discusses Q4 2013 Results - Earnings Call Transcript

Short Interest Moves 13% Lower For SUPN

Stocks Hitting 52-Week Highs

Supernus' Oxtellar XR Gets 3rd U.S. Patent - Analyst Blog

See More SUPN News...